IRCT20190716044229N1招募中3 期
Evaluating the effect of Metformin administration on pregnancy outcomes in healthy overweight pregnant women
Oroumia University of Medical Sciences0 个研究点目标入组 350 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 no limit（—）
- 性别
- Female
入选标准
- •Maternal age >=16 years
- •Singelton pregnancy
- •Body mass index: 25<=BMI<30
- •Negative history of Diabetes Mellitus
- •Negative history of previous medical conditions
- •Gestational age between 12 & 16 weeks
排除标准
- •Multiple gestation
- •Positive history of general medical conditions (e.g. diabetes)
- •BMI<25 or >=30
研究者
相似试验
招募中
2 期
An assessment of the use of metformin in preventing prednisone-induced elevation in blood glucose levels among blood cancer patients at Kenyatta National HospitalPACTR201807745027158ucy Ochola50
尚未招募
2 期
Metformin in the prevention of preeclampsiaPre-eclampsiapreeclampsia.IRCT20230730058975N1Esfahan University of Medical Sciences160
招募中
3 期
Evaluation of the effectiveness of metformin prophylaxis in preventing risperidone-induced hyperprolactinemia in children and adolescentsHyperprolactinemiaIRCT20200304046698N2Shahid Beheshti University of Medical Sciences40
进行中（未招募）
1 期
Clinical pilot study on the effect of Metformin in adipose children and adolescents with insulin-resistanceKlinische Pilotstudie zur Untersuchung der Wirkung von Metformin bei adipösen Kindern und Jugendlichen mit Insulin-Resistenz (IR) - not availableInsuline-resistance in adipose children and adolescentsEUCTR2004-003816-47-DEPädiatrische Endokrinologie, Universitätsmedizin Berlin, Charité
进行中（未招募）
1 期
Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.CTIS2024-511295-33-00Medica Scientia Innovation Research S.L.88